| 0 |
TOOTH ANKYLOSIS |
1 |
0.0769 |
| 1 |
PALISADED NEUTROPHILIC GRANULOMATOUS DERMATITIS |
1 |
0.0294 |
| 2 |
AIRWAY BURNS |
1 |
0.0222 |
| 3 |
PELVIC ORGAN INJURY |
1 |
0.0135 |
| 4 |
APPLICATION SITE FISSURE |
1 |
0.0111 |
| 5 |
STENOTROPHOMONAS SEPSIS |
1 |
0.0083 |
| 6 |
AIR EMBOLISM |
3 |
0.0064 |
| 7 |
DRY GANGRENE |
4 |
0.0063 |
| 8 |
TOOTH RESORPTION |
1 |
0.0047 |
| 9 |
EXPOSURE VIA INHALATION |
1 |
0.0046 |
| 10 |
SUBSTANCE ABUSER |
1 |
0.0044 |
| 11 |
RESPIRATORY FATIGUE |
1 |
0.0043 |
| 12 |
OESOPHAGEAL SQUAMOUS CELL CARCINOMA |
1 |
0.0041 |
| 13 |
FROSTBITE |
1 |
0.0033 |
| 14 |
POST PROCEDURAL CONTUSION |
1 |
0.0030 |
| 15 |
BENIGN NEOPLASM OF SKIN |
1 |
0.0030 |
| 16 |
NASAL SEPTAL OPERATION |
1 |
0.0028 |
| 17 |
MILIA |
1 |
0.0028 |
| 18 |
ACETABULUM FRACTURE |
1 |
0.0027 |
| 19 |
ALKALOSIS |
1 |
0.0026 |
| 20 |
HYPOCAPNIA |
1 |
0.0024 |
| 21 |
EXTREMITY NECROSIS |
4 |
0.0023 |
| 22 |
PYOGENIC GRANULOMA |
1 |
0.0021 |
| 23 |
SUBCUTANEOUS EMPHYSEMA |
2 |
0.0020 |
| 24 |
SEBORRHOEIC KERATOSIS |
2 |
0.0014 |
| 25 |
SUBSTANCE USE |
2 |
0.0013 |
| 26 |
FUNGAL SEPSIS |
1 |
0.0012 |
| 27 |
ADENOCARCINOMA OF COLON |
2 |
0.0011 |
| 28 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 29 |
AMAUROSIS FUGAX |
1 |
0.0009 |
| 30 |
PRODUCT LEAKAGE |
5 |
0.0009 |
| 31 |
VICTIM OF CRIME |
1 |
0.0008 |
| 32 |
APPLICATION SITE WARMTH |
1 |
0.0008 |
| 33 |
HAEMODYNAMIC INSTABILITY |
5 |
0.0007 |
| 34 |
TONSILLECTOMY |
1 |
0.0006 |
| 35 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 36 |
HOMICIDE |
1 |
0.0005 |
| 37 |
PNEUMOPERITONEUM |
1 |
0.0005 |
| 38 |
IMPULSE-CONTROL DISORDER |
1 |
0.0005 |
| 39 |
VASCULAR OCCLUSION |
1 |
0.0005 |
| 40 |
MELANOCYTIC NAEVUS |
2 |
0.0005 |
| 41 |
ONYCHOMYCOSIS |
2 |
0.0005 |
| 42 |
LIMB MASS |
1 |
0.0005 |
| 43 |
VENTRICULAR FIBRILLATION |
5 |
0.0004 |
| 44 |
EYELID DISORDER |
1 |
0.0004 |
| 45 |
HAEMANGIOMA |
1 |
0.0004 |
| 46 |
ORAL INTAKE REDUCED |
1 |
0.0004 |
| 47 |
SLOW SPEECH |
1 |
0.0004 |
| 48 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 49 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 50 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 51 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 52 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 53 |
HYPERTRIGLYCERIDAEMIA |
2 |
0.0003 |
| 54 |
ACNE CYSTIC |
1 |
0.0003 |
| 55 |
SQUAMOUS CELL CARCINOMA OF SKIN |
2 |
0.0003 |
| 56 |
SQUAMOUS CELL CARCINOMA |
3 |
0.0003 |
| 57 |
SUBSTANCE USE DISORDER |
1 |
0.0003 |
| 58 |
APPLICATION SITE VESICLES |
2 |
0.0003 |
| 59 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
| 60 |
HEPATIC FIBROSIS |
1 |
0.0003 |
| 61 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 62 |
SELF-MEDICATION |
1 |
0.0002 |
| 63 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 64 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 65 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 66 |
NERVE COMPRESSION |
2 |
0.0002 |
| 67 |
CHRONIC MYELOID LEUKAEMIA |
1 |
0.0002 |
| 68 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 69 |
FAECAL INCONTINENCE |
1 |
0.0002 |
| 70 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 71 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 72 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 73 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 74 |
HIP SURGERY |
1 |
0.0002 |
| 75 |
HYPERVENTILATION |
1 |
0.0002 |
| 76 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 77 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 78 |
DRUG DIVERSION |
1 |
0.0002 |
| 79 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 80 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 81 |
MEDICAL DEVICE COMPLICATION |
1 |
0.0001 |
| 82 |
PELVIC FRACTURE |
1 |
0.0001 |
| 83 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 84 |
PNEUMOTHORAX |
2 |
0.0001 |
| 85 |
ASPHYXIA |
1 |
0.0001 |
| 86 |
EMBOLISM |
1 |
0.0001 |
| 87 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 88 |
DRUG USE DISORDER |
1 |
0.0001 |
| 89 |
SKIN PLAQUE |
1 |
0.0001 |
| 90 |
ANURIA |
1 |
0.0001 |
| 91 |
GROIN PAIN |
1 |
0.0001 |
| 92 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 93 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 94 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 95 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 96 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 97 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 98 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 99 |
BREAST PAIN |
1 |
0.0001 |
| 100 |
BACK INJURY |
1 |
0.0001 |
| 101 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 102 |
SCAB |
1 |
0.0001 |
| 103 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 104 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 105 |
HEPATITIS |
2 |
0.0001 |
| 106 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 107 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 108 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 109 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 110 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 111 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 112 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 113 |
MASS |
1 |
0.0001 |
| 114 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 115 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 116 |
ANGINA PECTORIS |
2 |
0.0001 |
| 117 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 118 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 119 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 120 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 121 |
SCIATICA |
1 |
0.0001 |
| 122 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 123 |
BACK DISORDER |
1 |
0.0001 |
| 124 |
COMPLETED SUICIDE |
5 |
0.0001 |
| 125 |
SKIN DISORDER |
2 |
0.0001 |
| 126 |
ACCIDENTAL EXPOSURE TO PRODUCT |
6 |
0.0001 |
| 127 |
INJECTION SITE REACTION |
4 |
0.0001 |
| 128 |
METASTASES TO LIVER |
1 |
0.0001 |
| 129 |
HYPOXIA |
2 |
0.0001 |
| 130 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 131 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 132 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 133 |
FRACTURE |
1 |
0.0001 |
| 134 |
CHOLESTASIS |
1 |
0.0001 |
| 135 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 136 |
SPINAL FRACTURE |
1 |
0.0000 |
| 137 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 138 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 139 |
MOUTH ULCERATION |
1 |
0.0000 |
| 140 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 141 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 142 |
SKIN CANCER |
1 |
0.0000 |
| 143 |
PSORIASIS |
6 |
0.0000 |
| 144 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 145 |
LIVER DISORDER |
2 |
0.0000 |
| 146 |
SNEEZING |
1 |
0.0000 |
| 147 |
DRUG INTERACTION |
7 |
0.0000 |
| 148 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 149 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 150 |
COMA |
2 |
0.0000 |
| 151 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 152 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 153 |
SEDATION |
1 |
0.0000 |
| 154 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 155 |
SKIN LESION |
1 |
0.0000 |
| 156 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 157 |
DIVERTICULITIS |
1 |
0.0000 |
| 158 |
DRUG ABUSE |
3 |
0.0000 |
| 159 |
FEELING COLD |
1 |
0.0000 |
| 160 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 161 |
EYE IRRITATION |
2 |
0.0000 |
| 162 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 163 |
CATARACT |
2 |
0.0000 |
| 164 |
FEMUR FRACTURE |
1 |
0.0000 |
| 165 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 166 |
HIP FRACTURE |
1 |
0.0000 |
| 167 |
SWELLING FACE |
2 |
0.0000 |
| 168 |
GAIT INABILITY |
1 |
0.0000 |
| 169 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 170 |
GASTRIC DISORDER |
1 |
0.0000 |
| 171 |
HYPERKALAEMIA |
1 |
0.0000 |
| 172 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 173 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 174 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 175 |
DYSGEUSIA |
2 |
0.0000 |
| 176 |
EYE SWELLING |
1 |
0.0000 |
| 177 |
DISEASE PROGRESSION |
3 |
0.0000 |
| 178 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 179 |
CARDIAC ARREST |
2 |
0.0000 |
| 180 |
POLLAKIURIA |
1 |
0.0000 |
| 181 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 182 |
HYPOACUSIS |
1 |
0.0000 |
| 183 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 184 |
MALAISE |
10 |
0.0000 |
| 185 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 186 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 187 |
ADVERSE EVENT |
2 |
0.0000 |
| 188 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 189 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 190 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 191 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 192 |
DRY EYE |
1 |
0.0000 |
| 193 |
CELLULITIS |
1 |
0.0000 |
| 194 |
FLUID RETENTION |
1 |
0.0000 |
| 195 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 196 |
DRUG DEPENDENCE |
3 |
0.0000 |
| 197 |
TREMOR |
3 |
0.0000 |
| 198 |
WEIGHT DECREASED |
5 |
0.0000 |
| 199 |
NECK PAIN |
1 |
0.0000 |
| 200 |
BLISTER |
1 |
0.0000 |
| 201 |
HYPONATRAEMIA |
1 |
0.0000 |
| 202 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 203 |
DYSPHONIA |
1 |
0.0000 |
| 204 |
CHILLS |
2 |
0.0000 |
| 205 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 206 |
VERTIGO |
1 |
0.0000 |
| 207 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 208 |
AMNESIA |
1 |
0.0000 |
| 209 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 210 |
DEHYDRATION |
2 |
0.0000 |
| 211 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 212 |
VISION BLURRED |
2 |
0.0000 |
| 213 |
AGITATION |
1 |
0.0000 |
| 214 |
EPISTAXIS |
1 |
0.0000 |
| 215 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 216 |
FEELING ABNORMAL |
3 |
0.0000 |
| 217 |
TREATMENT FAILURE |
1 |
0.0000 |
| 218 |
BALANCE DISORDER |
1 |
0.0000 |
| 219 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 220 |
OFF LABEL USE |
10 |
0.0000 |
| 221 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 222 |
SWELLING |
1 |
0.0000 |
| 223 |
DYSPHAGIA |
1 |
0.0000 |
| 224 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 225 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 226 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 227 |
HYPERTENSION |
2 |
0.0000 |
| 228 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 229 |
SEPSIS |
1 |
0.0000 |
| 230 |
DYSPNOEA |
5 |
0.0000 |
| 231 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 232 |
SEIZURE |
1 |
0.0000 |
| 233 |
BACK PAIN |
2 |
0.0000 |
| 234 |
PALPITATIONS |
1 |
0.0000 |
| 235 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 236 |
ASTHENIA |
3 |
0.0000 |
| 237 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 238 |
HYPERHIDROSIS |
1 |
0.0000 |
| 239 |
RENAL FAILURE |
1 |
0.0000 |
| 240 |
INSOMNIA |
2 |
0.0000 |
| 241 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 242 |
INFECTION |
1 |
0.0000 |
| 243 |
HYPOAESTHESIA |
1 |
0.0000 |
| 244 |
NAUSEA |
5 |
0.0000 |
| 245 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 246 |
PNEUMONIA |
2 |
0.0000 |
| 247 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 248 |
DIZZINESS |
3 |
0.0000 |
| 249 |
FALL |
2 |
0.0000 |
| 250 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 251 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 252 |
COVID-19 |
1 |
0.0000 |
| 253 |
MUSCLE SPASMS |
1 |
0.0000 |
| 254 |
CHEST PAIN |
1 |
0.0000 |
| 255 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 256 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 257 |
HYPOTENSION |
1 |
0.0000 |
| 258 |
SOMNOLENCE |
1 |
0.0000 |
| 259 |
PAIN |
3 |
0.0000 |
| 260 |
ERYTHEMA |
1 |
0.0000 |
| 261 |
DEATH |
4 |
0.0000 |
| 262 |
RASH |
2 |
0.0000 |
| 263 |
CONSTIPATION |
1 |
0.0000 |
| 264 |
DEPRESSION |
1 |
0.0000 |
| 265 |
DECREASED APPETITE |
1 |
0.0000 |
| 266 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 267 |
ANXIETY |
1 |
0.0000 |
| 268 |
DIARRHOEA |
2 |
0.0000 |
| 269 |
PYREXIA |
1 |
0.0000 |
| 270 |
PRURITUS |
1 |
0.0000 |
| 271 |
ARTHRALGIA |
1 |
0.0000 |
| 272 |
VOMITING |
1 |
0.0000 |
| 273 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 274 |
FATIGUE |
1 |
0.0000 |